Cumberland Pharmaceuticals CPIX Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's stock-based comp?
- Cumberland Pharmaceuticals (CPIX) reported stock-based comp of $106.84K in Q1 2026.
- How has Cumberland Pharmaceuticals's stock-based comp changed year-over-year?
- Cumberland Pharmaceuticals's stock-based comp increased by 44.0% year-over-year, from $74.21K to $106.84K.
- What is the long-term trend for Cumberland Pharmaceuticals's stock-based comp?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's stock-based comp has grown at a -13.9% compound annual growth rate (CAGR), from $741.87K to $408.32K.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.